BBOT · Company research
BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times | BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) The Manila Times | View source ↗ | The Manila Times | Oct 12, 2026 | neutral | 0 | 0.6 |
| Book value per share of BridgeBio Oncology Therapeutics, Inc. – BMV:BBOT - TradingView | Book value per share of BridgeBio Oncology Therapeutics, Inc. – BMV:BBOT TradingView | View source ↗ | TradingView | Oct 10, 2026 | neutral | 0 | 0.6 |
| EBITDA per share of BridgeBio Oncology Therapeutics, Inc. – BMV:BBOT - TradingView | EBITDA per share of BridgeBio Oncology Therapeutics, Inc. – BMV:BBOT TradingView | View source ↗ | TradingView | Oct 9, 2026 | neutral | 0 | 0.6 |
| BridgeBio Oncology Therapeutics (Nasdaq:BBOT) - Stock Analysis - Simply Wall Street | BridgeBio Oncology Therapeutics (Nasdaq:BBOT) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Oct 6, 2026 | neutral | 0 | 0.6 |
| 343 shares withheld for taxes leave BridgeBio Oncology (BBOT) COO with 14,152 shares. - Stock Titan | 343 shares withheld for taxes leave BridgeBio Oncology (BBOT) COO with 14,152 shares. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| BridgeBio Oncology (BBOT) grants 43,700 options to principal accounting officer - Stock Titan | BridgeBio Oncology (BBOT) grants 43,700 options to principal accounting officer Stock Titan | View source ↗ | Stock Titan | Sep 14, 2026 | neutral | 0 | 0.6 |
| BridgeBio Oncology Therapeutics (BBOT) Bets Big On A Narrower KRAS Playbook - Yahoo Finance | BridgeBio Oncology Therapeutics (BBOT) Bets Big On A Narrower KRAS Playbook Yahoo Finance | View source ↗ | Yahoo Finance | Sep 12, 2026 | neutral | 0 | 0.6 |
| Three healthcare talks from BridgeBio Oncology will stream online in September - Stock Titan | Three healthcare talks from BridgeBio Oncology will stream online in September Stock Titan | View source ↗ | Stock Titan | Sep 1, 2026 | neutral | 0 | 0.6 |
| BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire | BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire | View source ↗ | GlobeNewswire | Aug 11, 2026 | neutral | 0 | 0.6 |
| BridgeBio Oncology Therapeutics: KRAS Program Data Due H2 May Reignite Bulls (BBOT) - Seeking Alpha | BridgeBio Oncology Therapeutics: KRAS Program Data Due H2 May Reignite Bulls (BBOT) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 13, 2026 | neutral | 0 | 0.6 |
| Which stocks are gapping on Wednesday? - ChartMill | Which stocks are gapping on Wednesday? ChartMill | View source ↗ | ChartMill | Jul 8, 2026 | neutral | 0 | 0.6 |
| Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential? - Yahoo Finance | Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| BBOT Forecast — Price Target — Prediction for 2027 - TradingView | BBOT Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Stock Price: Oct 14 Close $2.91 - Gotrade | BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Stock Price: Oct 14 Close $2.91 Gotrade | View source ↗ | Gotrade | May 4, 2026 | neutral | 0 | 0.6 |
| BBOT shakes up leadership as RAS competitors get more visibility - BioSpace | BBOT shakes up leadership as RAS competitors get more visibility BioSpace | View source ↗ | BioSpace | Apr 23, 2026 | neutral | 0 | 0.6 |
| BridgeBio Oncology Therapeutics (BBOT) Stock Price, News & Analysis - MarketBeat | BridgeBio Oncology Therapeutics (BBOT) Stock Price, News & Analysis MarketBeat | View source ↗ | MarketBeat | Jan 16, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Aug 14, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.